Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

BACKGROUND: It is well known that patient characteristics and survival outcomes in randomized trials may not necessarily be similar to those in real-life clinical practice. The aim of the present study was to analyse second line treatment strategies in the real-world practice and to estimate the out...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Cancer
Главные авторы: Lakomy, Radek, Poprach, Alexandr, Bortlicek, Zbynek, Melichar, Bohuslav, Chloupkova, Renata, Vyzula, Rostislav, Zemanova, Milada, Kopeckova, Katerina, Svoboda, Marek, Slaby, Ondrej, Kiss, Igor, Studentova, Hana, Juracek, Jaroslav, Fiala, Ondrej, Kopecky, Jindrich, Finek, Jindrich, Dusek, Ladislav, Hejduk, Karel, Buchler, Tomas
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740580/
https://ncbi.nlm.nih.gov/pubmed/29268716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3901-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы